Skip to Main Content

Author Details

Pedro Cabrales
University of California
2003
263
40
PMIDPaper TitleJournal TitlePublished Year
38059289High-molecular-weight linear polymers improve microvascular perfusion after extracorporeal circulation.J Appl Physiol (1985)2024
38059289High-molecular-weight linear polymers improve microvascular perfusion after extracorporeal circulation.J Appl Physiol (1985)2024
36581694Intravascularly infused extracellular matrix as a biomaterial for targeting and treating inflamed tissues.Nat Biomed Eng2023
37673369Changes in oxygen delivery during experimental models of cerebral malaria.Exp Parasitol2023
37843033The Molecular Size of Bioengineered Oxygen Carriers Determines Tissue Oxygenation in a Hypercholesterolemia Guinea Pig Model of Hemorrhagic Shock and Resuscitation.Mol Pharm2023
36581694Intravascularly infused extracellular matrix as a biomaterial for targeting and treating inflamed tissues.Nat Biomed Eng2023
36960712GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model.Br J Haematol2023
36960054Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME).Front Immunol2023
37268039Polymerized human hemoglobin with low and high oxygen affinity in trauma models.Transl Res2023
37382299Data Management 101 for drug developers: A peek behind the curtain.Clin Transl Sci2023
37313460RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist.Front Oncol2023
37373527The Double-Edged Sword of Erythrocytes in Health and Disease via Their Adhesiveness.Int J Mol Sci2023
37230699Prony Analysis of Left Ventricle Pressure and Volume.Med Eng Phys2023
36920652A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation.Drugs2023
37503560TGF-β: the apex predator of immune checkpoints.Future Oncol2023
37843033The Molecular Size of Bioengineered Oxygen Carriers Determines Tissue Oxygenation in a Hypercholesterolemia Guinea Pig Model of Hemorrhagic Shock and Resuscitation.Mol Pharm2023
37503560TGF-β: the apex predator of immune checkpoints.Future Oncol2023
37673369Changes in oxygen delivery during experimental models of cerebral malaria.Exp Parasitol2023
37313460RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist.Front Oncol2023
37382299Data Management 101 for drug developers: A peek behind the curtain.Clin Transl Sci2023
37373527The Double-Edged Sword of Erythrocytes in Health and Disease via Their Adhesiveness.Int J Mol Sci2023
37268039Polymerized human hemoglobin with low and high oxygen affinity in trauma models.Transl Res2023
37230699Prony Analysis of Left Ventricle Pressure and Volume.Med Eng Phys2023
36960712GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model.Br J Haematol2023
36960054Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME).Front Immunol2023
36920652A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation.Drugs2023
35168074Nitric oxide releasing nanoparticles reduce inflammation in a small animal model of ARDS.Biomed Pharmacother2022
35530283The small molecule NLRP3 inhibitor RRx-001 potentiates regorafenib activity and attenuates regorafenib-induced toxicity in mice bearing human colorectal cancer xenografts.Am J Cancer Res2022
36308920Apohemoglobin-haptoglobin complex alleviates iron toxicity in mice with β-thalassemia via scavenging of cell-free hemoglobin and heme.Biomed Pharmacother2022
35522555Hyperspectral wide-field-of-view imaging to study dynamic microcirculatory changes during hypoxia.Am J Physiol Heart Circ Physiol2022
35469768Implications of microvascular dysfunction and nitric oxide mediated inflammation in severe COVID-19 infection.Am J Med Sci2022
36443351Safety and efficacy of human polymerized hemoglobin on guinea pig resuscitation from hemorrhagic shock.Sci Rep2022
34913740Attenuating ischemia-reperfusion injury with polymerized albumin.J Appl Physiol (1985)2022
35168074Nitric oxide releasing nanoparticles reduce inflammation in a small animal model of ARDS.Biomed Pharmacother2022
35085033Extracorporeal circulation impairs microcirculation perfusion and organ function.J Appl Physiol (1985)2022
35067580The Disconnect Between Extracorporeal Circulation and the Microcirculation: A Review.ASAIO J2022
35469768Implications of microvascular dysfunction and nitric oxide mediated inflammation in severe COVID-19 infection.Am J Med Sci2022
35530283The small molecule NLRP3 inhibitor RRx-001 potentiates regorafenib activity and attenuates regorafenib-induced toxicity in mice bearing human colorectal cancer xenografts.Am J Cancer Res2022
35522555Hyperspectral wide-field-of-view imaging to study dynamic microcirculatory changes during hypoxia.Am J Physiol Heart Circ Physiol2022
36443351Safety and efficacy of human polymerized hemoglobin on guinea pig resuscitation from hemorrhagic shock.Sci Rep2022
36308920Apohemoglobin-haptoglobin complex alleviates iron toxicity in mice with β-thalassemia via scavenging of cell-free hemoglobin and heme.Biomed Pharmacother2022
35067580The Disconnect Between Extracorporeal Circulation and the Microcirculation: A Review.ASAIO J2022
34913740Attenuating ischemia-reperfusion injury with polymerized albumin.J Appl Physiol (1985)2022
35085033Extracorporeal circulation impairs microcirculation perfusion and organ function.J Appl Physiol (1985)2022
33104250Safety profile of high molecular weight polymerized hemoglobins.Transfusion2021
34016002Vascular priming with RRx-001 to increase the uptake and accumulation of temozolomide and irinotecan in orthotopically implanted gliomas.J Drug Target2021
33703947High fat high sucrose diet-induced dyslipidemia in guinea pigs.J Appl Physiol (1985)2021
34072241Red Blood Cells: Tethering, Vesiculation, and Disease in Micro-Vascular Flow.Diagnostics (Basel)2021
33946824RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor Vasculature.Int J Mol Sci2021
33569311In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit.Transl Lung Cancer Res2021
  • 1 - 50 of 526

Recommended Authors

Trauma and Transfusion Medicine Research Center, University of Pittsburgh
Career Start Year 2013
Number of shared co-authors 3
Montefiore Medical Center, Albert Einstein College of Medicine
Career Start Year 2012
Number of shared co-authors 4
University of Pittsburgh
Career Start Year 2010
Number of shared co-authors 4
University of Pittsburgh Medical Center
Career Start Year 2008
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 0
University of Washington and Harborview Medical Center
Career Start Year 2000
Number of shared co-authors 0
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Career Start Year 2000
Number of shared co-authors 8
Beth Israel Deaconess Medical Center and Harvard Medical School
Career Start Year 1999
Number of shared co-authors 2
Department of Surgery University of Cincinnati College of Medicine
Career Start Year 1998
Number of shared co-authors 0
Erasmus University Medical Center
Career Start Year 1998
Number of shared co-authors 0
Vanderbilt University Medical Center, 1211 Medical Center Drive
Career Start Year 1997
Number of shared co-authors 0
Goethe University, University Hospital Frankfurt
Career Start Year 1997
Number of shared co-authors 1
The University of Texas Southwestern Medical Center
Career Start Year 1996
Number of shared co-authors 0
Center for Biologics Evaluation and Research
Career Start Year 1996
Number of shared co-authors 4
Center for Critical Care Nephrology, University of Pittsburgh
Career Start Year 1996
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1996
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 1995
Number of shared co-authors 1
University of Groningen, University Medical Center Groningen
Career Start Year 1994
Number of shared co-authors 0
Clinical Center/Critical Care Medicine Department, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 1
Duke University Health System
Career Start Year 1991
Number of shared co-authors 6
Harborview Medical Center
Career Start Year 1989
Number of shared co-authors 4
Vitalant Research Institute
Career Start Year 1987
Number of shared co-authors 4
CHU de Bicetre
Career Start Year 1986
Number of shared co-authors 0
McGowan Institute for Regenerative Medicine, University of Pittsburgh
Career Start Year 1984
Number of shared co-authors 0
United States Army Institute of Surgical Research
Career Start Year 1977
Number of shared co-authors 4
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology
Career Start Year 1977
Number of shared co-authors 0
Center for Biologics Evaluation and Research Food and Drug Administration (FDA)
Career Start Year 1977
Number of shared co-authors 5
Center for Blood Oxygen Transport and Hemostasis, University of Maryland
Career Start Year 1974
Number of shared co-authors 7
and Institute of Engineering in Medicine, University of California
Career Start Year 1957
Number of shared co-authors 4

Collaborators

University of California
Co-authored papers 93
Co-authored papers 85
Co-authored papers 19
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 18
Co-authored papers 15
Co-authored papers 12
Co-authored papers 11
Co-authored papers 7
Co-authored papers 5
Co-authored papers 5
university of california san diego
Co-authored papers 3
Massachusetts Institute of Technology
Co-authored papers 3
University of Maryland School of Medicine
Co-authored papers 3
University of Alabama at Birmingham, USA Center for Free Radical Biology
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Technische Universitat Braunschweig, Helmholtz Centre for Infection Research
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University of California
Co-authored papers 2
University of California
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 2
University of California San Diego
Co-authored papers 2
Co-authored papers 2
University College Dublin
Co-authored papers 2
Vita-Salute San Raffaele University
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Co-authored papers 1
Keio University School of Medicine
Co-authored papers 1